HomeNewsPoliticsTamil Nadu Election 2021: DMK's Kanimozhi, COVID-19 positive, casts vote in PPE suit

Tamil Nadu Election 2021: DMK's Kanimozhi, COVID-19 positive, casts vote in PPE suit

Kanimozhi arrived in an ambulance from the hospital where she is being treated for the infectious disease and voted in the single-phase assembly election's final hour, earmarked for COVID-19 patients.

April 07, 2021 / 11:38 IST
Story continues below Advertisement
DMK leader and MP Kanimozhi casting her vote in a PPE suit on April 6
DMK leader and MP Kanimozhi casting her vote in a PPE suit on April 6

Dravida Munnetra Kazhagam (DMK) leader and Member of Parliament Kanimozhi, who had tested positive for COVID-19 recently, cast her vote clad in a personal protective equipment (PPE) suit, at a polling station in Chennai's Mylapore on April 6.

The 53-year-old DMK leader arrived in an ambulance from the hospital where she is being treated for the infectious disease and voted in the single-phase election's final hour, earmarked for COVID-19 patients.

Story continues below Advertisement

Kanimozhi was campaigning across Tamil Nadu ahead of the assembly polls before she tested positive for COVID-19 on April 3.

Follow our LIVE blog for the latest updates of the 2021 assembly elections campaign

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

"I was able to vote today, despite my health condition. Thanks to the Election Commission for ensuring that being unwell was not an impediment to choosing our next Government," the Lok Sabha member from Thoothukkudi parliamentary constituency said in a tweet along with her picture from the polling booth.